- Home
- GVH vs PRFX Comparison
GVH vs PRFX Comparison
Compare GVH & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GVH | PRFX |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | Australia | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.7M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GVH | PRFX |
|---|---|---|
| Price | $1.33 | $0.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $80.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 100.8K |
| Earning Date | 02-15-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 11.95 | N/A |
| Revenue | ★ $21,878,867.00 | N/A |
| Revenue This Year | $141,706.20 | N/A |
| Revenue Next Year | $3.35 | N/A |
| P/E Ratio | $0.11 | ★ N/A |
| Revenue Growth | ★ 24.52 | N/A |
| 52 Week Low | $1.28 | $0.61 |
| 52 Week High | $364.00 | $6.65 |
Technical Indicators
Market Signals| Indicator | GVH | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 30.20 | 51.03 |
| Support Level | $1.31 | $0.66 |
| Resistance Level | $1.58 | $0.74 |
| Average True Range (ATR) | 0.46 | 0.07 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 1.37 | 79.35 |
Price Performance
Historical ComparisonAbout GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.